No abstract available
Publication types
-
Letter
-
Randomized Controlled Trial
-
Research Support, N.I.H., Extramural
-
Research Support, N.I.H., Intramural
MeSH terms
-
Adult
-
Antipsychotic Agents / adverse effects*
-
Appetite Depressants / adverse effects
-
Appetite Depressants / therapeutic use*
-
Body Mass Index
-
Body Weight / drug effects
-
Brain / drug effects*
-
Brain / metabolism
-
Cannabinoid Receptor Antagonists / adverse effects
-
Cannabinoid Receptor Antagonists / therapeutic use*
-
Double-Blind Method
-
Drug Inverse Agonism
-
Eating / drug effects
-
Energy Intake / drug effects
-
Female
-
Humans
-
Male
-
Middle Aged
-
Overweight / chemically induced
-
Overweight / diagnosis
-
Overweight / drug therapy*
-
Overweight / psychology
-
Pilot Projects
-
Piperidines / adverse effects
-
Piperidines / therapeutic use*
-
Pyrazoles / adverse effects
-
Pyrazoles / therapeutic use*
-
Receptor, Cannabinoid, CB1 / antagonists & inhibitors*
-
Receptor, Cannabinoid, CB1 / metabolism
-
Rimonabant
-
Satiety Response / drug effects*
-
Schizophrenia / diagnosis
-
Schizophrenia / drug therapy*
-
Schizophrenic Psychology*
-
Signal Transduction / drug effects
-
Treatment Outcome
Substances
-
Antipsychotic Agents
-
Appetite Depressants
-
CNR1 protein, human
-
Cannabinoid Receptor Antagonists
-
Piperidines
-
Pyrazoles
-
Receptor, Cannabinoid, CB1
-
Rimonabant